CWEB vs. LABS, HEXO, VIR, ZOM, META, DB, VM, NRTH, MRV, and FLWR
Should you be buying Charlotte's Web stock or one of its competitors? The main competitors of Charlotte's Web include MediPharm Labs (LABS), HEXO (HEXO), Viridium Pacific Group (VIR), Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM), Meta Growth (META), Decibel Cannabis (DB), Voyageur Pharmaceuticals (VM), 48North Cannabis (NRTH), Nuvo Pharmaceuticals (MRV), and Flowr (FLWR). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Charlotte's Web vs.
Charlotte's Web (TSE:CWEB) and MediPharm Labs (TSE:LABS) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability.
MediPharm Labs received 25 more outperform votes than Charlotte's Web when rated by MarketBeat users. Likewise, 65.79% of users gave MediPharm Labs an outperform vote while only 0.00% of users gave Charlotte's Web an outperform vote.
In the previous week, Charlotte's Web and Charlotte's Web both had 1 articles in the media. MediPharm Labs' average media sentiment score of 1.11 beat Charlotte's Web's score of -0.68 indicating that MediPharm Labs is being referred to more favorably in the news media.
MediPharm Labs has a net margin of -30.56% compared to Charlotte's Web's net margin of -66.35%. MediPharm Labs' return on equity of -24.41% beat Charlotte's Web's return on equity.
MediPharm Labs has higher revenue and earnings than Charlotte's Web. MediPharm Labs is trading at a lower price-to-earnings ratio than Charlotte's Web, indicating that it is currently the more affordable of the two stocks.
3.3% of Charlotte's Web shares are held by institutional investors. Comparatively, 0.7% of MediPharm Labs shares are held by institutional investors. 11.3% of Charlotte's Web shares are held by company insiders. Comparatively, 4.5% of MediPharm Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Charlotte's Web has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, MediPharm Labs has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.
Summary
MediPharm Labs beats Charlotte's Web on 10 of the 14 factors compared between the two stocks.
Get Charlotte's Web News Delivered to You Automatically
Sign up to receive the latest news and ratings for CWEB and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Charlotte's Web Competitors List
Related Companies and Tools
This page (TSE:CWEB) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy CWEB Stock Free CWEB Stock Alerts